Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine

Clinical and Vaccine Immunology

Volumn 16, Issue 8, 2009, Pages 1236-1246

  Cambron, Pierre ^a   Jacquet, Jeanne Marie ^a   Hoet, Bernard ^a   Lievens, Marc ^a  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VACCINES, SYNTHETIC;

EID: 68149156208     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00431-08     Document Type: Article

References (16)

1. Barker, L. F., D. Lorenz, S. C. Rastogi, J. S. Finlayson, and E. B. Seligmann. 1977. Study of a proposed international reference preparation for antihepatitis B immunoglobulin. Expert Committee on Biological Standardization technical report series. World Health Organization, Geneva Switzerland.
2. Braggio, S., R. J. Barnaby, P. Grossi, and M. Cugola. 1996. A strategy for validation of bioanalytical methods. J. Pharm. Biomed. Anal. 14:375-388.
3. Findlay, J. W. A., W. C. Smith, J. W. Lee, G. D. Nordblom, I. Das, B. S. DeSilva, M. N. Khan, and R. R. Bowsher. 2000. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J. Pharm. Biomed. Anal. 21:1249-1273.
4. Hauser, P., P. Voet, E. Simoen, H. C. Thomas, J. Pêtre, M. De Wilde, and J. Stephenne. 1987. Immunological properties of recombinant HBsAg produced in yeast. Postgrad. Med. J. 63:83-91.
5. Keating, G. M., and S. Noble. 2003. Recombinant hepatitis B vaccine (Engerix™-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 63:1021-1051.
6. Miller, K. J., R. R. Bowsher, A. Celniker, J. Gibbons, S. Gupta, J. W. Lee, S. J. Swanson, W. C. Smith, and R. S. Weiner. 2001. Workshop on bioanalytical methods validation for macromolecules: summary report. Pharmacol. Res. 18:1373-1383.
7. Nakane, P. K., and A. Kawaoi. 1974. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22:1084-1091.
8. Pêtre, J., F. Van Wijnendaele, B. De Neys, K. Conrath, O. Van Opstal, P. Hauser, T. Rutgers, T. Cabezon, C. Capiau, N. Harford, et al. 1987. Development of a hepatitis B vaccine from transformed yeast cells. Postgrad. Med. J. 63(Suppl. 2):73-81.
9. Plikaytis, B. D., S. H. Turner, L. L. Gheesling, and G. M. Carlone. 1991. Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody level by enzyme-linked-imunosorbent assay. J. Clin. Microbiol. 29:1439-1446.
10. Rodbard, D., and G. R. Frazier. 1975. Statistical analysis of radioligand assay data. Methods Enzymol. 37:3-22.
11. Soulier, J. P., and A. M. Couroucé-Pauty. 1973. New determinants of hepatitis B antigen (Au or HB antigen). Vox Sang. 25:212-234.
12. Tan, C. Y., and B. Iglewicz. 1999. Measurement-methods comparisons and linear statistical relationship. Technometrics 41:192-201.
13. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation, and Research Center for Veterinary Medicine. 2001. Guidance for industry. Bioanalytical method validation. U.S. Department of Health and Human Services, Washington, D.C.
14. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research. 2001. Guidance for industry. Statistical approaches to establish bioequivalence. U.S. Department of Health and Human Services, Washington, D.C.
15. Vnek, J., and A. M. Prince. 1976. Large-scale purification of hepatitis B surface antigen. J. Clin. Microbiol. 3:626-631.
16. World Health Organization. 2004. Hepatitis B vaccines W.H.O. position paper. Wkly. Epidemiol. Rep. 79:255-263.